The Prognostic Impact of Jumonji Domain-containing 2B in Patients with Resected Lung Adenocarcinoma.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Anticancer Research

• Publication date

  2016-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.21873/ANTICANRES.11046PMID 27630338
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Critical roles of non-histone protein lysine methylation in human tumorigenesis

  2015cited by this paper
• JMJD2B as a potential diagnostic immunohistochemical marker for hepatocellular carcinoma: a tissue microarray-based study.

  2015cited by this paper
• Jumonji domain-containing protein 2B silencing induces DNA damage response via STAT3 pathway in colorectal cancer

  2014cited by this paper
• The mutations of the EGFR and K-ras genes in resected stage I lung adenocarcinoma and their clinical significance

  2014cited by this paper
• ALK inhibitors: what is the best way to treat patients with ALK+ non-small-cell lung cancer?

  2014cited by this paper
• The future of epigenetic therapy in solid tumours—lessons from the past

  2013cited by this paper
• KDM4/JMJD2 histone demethylases: epigenetic regulators in cancer cells.

  2013cited by this paper
• CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1-2 study.

  2013cited by this paper
• JMJD2B Promotes Epithelial–Mesenchymal Transition by Cooperating with β-Catenin and Enhances Gastric Cancer Metastasis

  2013cited by this paper
• RET, ROS1 and ALK fusions in lung cancer

  2012cited by this paper
• Cancer epigenetics: from mechanism to therapy.

  2012cited by this paper
• Transient JMJD2B-Mediated Reduction of H3K9me3 Levels Improves Reprogramming of Embryonic Stem Cells into Cloned Embryos

  2012cited by this paper
• The Histone Demethylase JMJD2B Plays an Essential Role in Human Carcinogenesis through Positive Regulation of Cyclin-Dependent Kinase 6

  2011cited by this paper
• The histone demethylase JMJD2B is regulated by estrogen receptor alpha and hypoxia, and is a key mediator of estrogen induced growth.

  2010cited by this paper
• Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial.

  2010cited by this paper
• Japanese Lung Cancer Registry Study: First Prospective Enrollment of a Large Number of Surgical and Nonsurgical Cases in 2002

  2010cited by this paper
• Regulation of Jumonji-domain-containing histone demethylases by hypoxia-inducible factor (HIF)-1alpha.

  2008cited by this paper
• The Histone Demethylases JMJD1A and JMJD2B Are Transcriptional Targets of Hypoxia-inducible Factor HIF*

  2008cited by this paper
• Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer

  2007cited by this paper
• Jmjd2b antagonizes H3K9 trimethylation at pericentric heterochromatin in mammalian cells.

  2006cited by this paper
• Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.

  2004cited by this paper
• Histone demethylation mediated by the nuclear amine oxidase homolog LSD1.

  2004cited by this paper
• Identification and characterization of JMJD2 family genes in silico.

  2004cited by this paper
• Anticancer drugs: To the rescue?

  2004cited by this paper
• Heterochromatin and Epigenetic Control of Gene Expression

  2003cited by this paper
• Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

  1998cited by this paper

• Genomic and immunological profiling reveals novel prognostic biomarkers for limited-stage small cell lung cancer

  2025cites this paper
• Histone demethylase KDM4B contributes to advanced clear cell renal carcinoma and association with copy number variations and cell cycle progression

  2023cites this paper
• [Expression and significance of jumonji domain-containing protein 2B and hypoxia inducible factor-1α in non-Hodgkin lymphoma tissues in children].

  2023cites this paper
• Inhibitors of Jumonji C domain-containing histone lysine demethylases overcome cisplatin and paclitaxel resistance in non-small cell lung cancer through APC/Cdh1-dependent degradation of CtIP and PAF15

  2022cites this paper
• The Diverse Roles of Histone Demethylase KDM4B in Normal and Cancer Development and Progression

  2022cites this paper
• Application of Artificial Intelligence Technology in Oncology: Towards the Establishment of Precision Medicine

  2020cites this paper
• Advances in histone demethylase KDM4 as cancer therapeutic targets

  2020cites this paper
• PD-L1 Predicts Poor Prognosis in Surgically Resected Limited Stage Small-Cell Lung Cancer

  2020cites this paper
• JMJD2 promotes acquired cisplatin resistance in non-small cell lung carcinoma cells

  2019cites this paper
• Programmed Death-ligand 1 Expression With Clone 22C3 in Non-small Cell Lung Cancer: A Single Institution Experience

  2019cites this paper
• Establishment of a nine‐gene prognostic model for predicting overall survival of patients with endometrial carcinoma

  2018cites this paper